Recently, Barry Marshall, a Nobel laureate in Physiology or Medicine, expressed that artificial intelligence (AI) is poised to usher in revolutionary transformations. It will notably cut down on the workload and the frequency of trial-and-error endeavors. The new wave of young scientists displays a keen enthusiasm for AI, and this cutting-edge technology is set to make its way into laboratory research.

At present, certain genetic diseases can be treated by implanting replacement genes. In the past, while copious amounts of data could be gathered, there was a dearth of user-friendly analytical tools to sift out crucial information. Now, thanks to the power of AI engines, data analysis can be accomplished with remarkable efficiency. This allows research to be more targeted and significantly enhances productivity.

The human genome is composed of 3 billion base pairs, and a multitude of major diseases are linked to genes. Looking ahead, AI has the potential to aid in uncovering a greater number of diseases that can be prevented through genetic screening.